x
Filter:
Filters applied
- Protein Synthesis and Degradation
- Essalmani, RachidRemove Essalmani, Rachid filter
- Ly, KévinRemove Ly, Kévin filter
- HepG2 cellsRemove HepG2 cells filter
- glypican-3Remove glypican-3 filter
Protein Synthesis and Degradation
1 Results
- Cell BiologyOpen Access
An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells
Journal of Biological ChemistryVol. 291Issue 47p24676–24687Published online: October 7, 2016- Kévin Ly
- Rachid Essalmani
- Roxane Desjardins
- Nabil G. Seidah
- Robert Day
Cited in Scopus: 10The mechanism of LDL receptor (LDLR) degradation mediated by the proprotein convertase subtilisin/kexin type 9 (PCSK9) has been extensively studied; however, many steps within this process remain unclear and still require characterization. Recent studies have shown that PCSK9 lacking its Cys/His-rich domain can still promote LDLR internalization, but the complex does not reach the lysosome suggesting the presence of an additional interaction partner(s). In this study we carried out an unbiased screening approach to identify PCSK9-interacting proteins in the HepG2 cells' secretome using co-immunoprecipitation combined with mass spectrometry analyses.